CraniUS Therapeutics
PrivateLast Round
Series B
Jan 28, 2026
Total Funding Raised
$40.4M
Company Overview
CraniUS Therapeutics is a neurotechnology company developing a fully implantable platform to bypass the blood-brain barrier for long-term, programmable drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CraniUS Therapeutics Comps
Public and private peers based on sector, stage, and business model.
CraniUS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 28, 2026 | ||||
| Grant | Jun 26, 2024 | ||||
| Series A | Sep 27, 2022 |
CraniUS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maryland Department of Commerce | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2026
$20M round completed.
- Jan 28, 2026
NeuroPASS platform for drug delivery and brain monitoring announced.
CraniUS Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CraniUS Therapeutics's valuation, stock price, and market status.
